205 related articles for article (PubMed ID: 11222104)
1. Paramyxovirus fusion (F) protein: a conformational change on cleavage activation.
Dutch RE; Hagglund RN; Nagel MA; Paterson RG; Lamb RA
Virology; 2001 Mar; 281(1):138-50. PubMed ID: 11222104
[TBL] [Abstract][Full Text] [Related]
2. Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity.
Zhou J; Dutch RE; Lamb RA
Virology; 1997 Dec; 239(2):327-39. PubMed ID: 9434724
[TBL] [Abstract][Full Text] [Related]
3. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation.
Paterson RG; Russell CJ; Lamb RA
Virology; 2000 Apr; 270(1):17-30. PubMed ID: 10772976
[TBL] [Abstract][Full Text] [Related]
4. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.
Yao Q; Compans RW
Virology; 1996 Sep; 223(1):103-12. PubMed ID: 8806544
[TBL] [Abstract][Full Text] [Related]
5. Conserved leucine residue in the head region of morbillivirus fusion protein regulates the large conformational change during fusion activity.
Plattet P; Langedijk JP; Zipperle L; Vandevelde M; Orvell C; Zurbriggen A
Biochemistry; 2009 Sep; 48(38):9112-21. PubMed ID: 19705836
[TBL] [Abstract][Full Text] [Related]
6. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
Joshi SB; Dutch RE; Lamb RA
Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion.
Ghosh JK; Shai Y
J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019
[TBL] [Abstract][Full Text] [Related]
8. The antibodies directed against N-terminal heptad-repeat peptide of hRSV fusion protein and its analog-5-Helix inhibit virus infection in vitro.
Ni L; Zhao L; Gao GF; Qian Y; Tien P
Biochem Biophys Res Commun; 2005 Jun; 331(4):1358-64. PubMed ID: 15883025
[TBL] [Abstract][Full Text] [Related]
9. Basis for fusion inhibition by peptides: analysis of the heptad repeat regions of the fusion proteins from Nipah and Hendra viruses, newly emergent zoonotic paramyxoviruses.
Xu Y; Gao S; Cole DK; Zhu J; Su N; Wang H; Gao GF; Rao Z
Biochem Biophys Res Commun; 2004 Mar; 315(3):664-70. PubMed ID: 14975752
[TBL] [Abstract][Full Text] [Related]
10. Role of the simian virus 5 fusion protein N-terminal coiled-coil domain in folding and promotion of membrane fusion.
West DS; Sheehan MS; Segeleon PK; Dutch RE
J Virol; 2005 Feb; 79(3):1543-51. PubMed ID: 15650180
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and biophysical analysis of heptad repeat regions from the fusion protein of Menangle virus, a newly emergent paramyxovirus.
Zhu JQ; Zhang CW; Rao Z; Tien P; Gao GF
Arch Virol; 2003 Jul; 148(7):1301-16. PubMed ID: 12827462
[TBL] [Abstract][Full Text] [Related]
12. A glycine to alanine substitution in the paramyxovirus SV5 fusion peptide increases the initial rate of fusion.
Bagai S; Lamb RA
Virology; 1997 Nov; 238(2):283-90. PubMed ID: 9400601
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the membrane proximal heptad repeat of the newcastle disease virus fusion protein.
McGinnes LW; Sergel T; Chen H; Hamo L; Schwertz S; Li D; Morrison TG
Virology; 2001 Oct; 289(2):343-52. PubMed ID: 11689056
[TBL] [Abstract][Full Text] [Related]
14. The fusion core complex of the peste des petits ruminants virus is a six-helix bundle assembly.
Rahaman A; Srinivasan N; Shamala N; Shaila MS
Biochemistry; 2003 Feb; 42(4):922-31. PubMed ID: 12549911
[TBL] [Abstract][Full Text] [Related]
15. Mutants of the paramyxovirus SV5 fusion protein: regulated and extensive syncytium formation.
Ward CD; Paterson RG; Lamb RA
Virology; 1995 May; 209(1):242-9. PubMed ID: 7747476
[TBL] [Abstract][Full Text] [Related]
16. Identification of critical antibody-binding sites in the HIV-1 gp41 six-helix bundle core as potential targets for HIV-1 fusion inhibitors.
Li J; Chen X; Huang J; Jiang S; Chen YH
Immunobiology; 2009; 214(1):51-60. PubMed ID: 19159827
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling.
Young JK; Hicks RP; Wright GE; Morrison TG
Virology; 1997 Nov; 238(2):291-304. PubMed ID: 9400602
[TBL] [Abstract][Full Text] [Related]
18. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein.
Russell R; Paterson RG; Lamb RA
Virology; 1994 Feb; 199(1):160-8. PubMed ID: 8116239
[TBL] [Abstract][Full Text] [Related]
19. [Expression and purification of heptad repeat region of the mumps virus F protein and analysis of characteristics].
Liu YY; Feng MG; Zhu JQ; Jiang LJ; Tien P
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):377-81. PubMed ID: 15971609
[TBL] [Abstract][Full Text] [Related]
20. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
